Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN64,3764,4-0,17
Msft-0,45
Nokia3,3553,45251,23
IBM0,62
Mercedes-Benz Group AG63,4463,45-0,11
PFE1,59
19.06.2024 1:38:48
Indexy online
AD Index online
select
AD Index online
 

  • 18.06.2024
Mannatech (MTEX.O, NASDAQ Cons)
Závěr k 18.6.2024 Změna (%) Změna (USD) Objem obchodů (ks)
7,22 0,00 0,00 134
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.06.2024
Popis společnosti
Obecné informace
Název společnostiMannatech Inc
TickerMTEX
Kmenové akcie:Ordinary Shares
RICMTEX.O
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 213
Akcie v oběhu k 30.04.2024 1 884 814
MěnaUSD
Kontaktní informace
Ulice1410 Lakeside Parkway, Suite 200
MěstoFLOWER MOUND
PSČ75028
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon19 724 717 400
Fax19724718135

Business Summary: Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, Essentials, and Home Living. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies. Home Living includes Organt and PURO.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Mannatech Inc revenues decreased 14% to $29.4M. Net income increased 95% to $1.2M. Revenues reflect Consolidated Product Sales segment decrease of 13% to $27.9M, Consolidated Pack Sales segment decrease of 48% to $1.1M, Asia Pacific segment decrease of 19% to $17.1M, EMEA segment decrease of 16% to $2.1M. Net income reflects Commissions and incentives decrease of 14% to $11.7M (expense).
Odvětvová klasifikace
TRBC2012Special Foods & Wellbeing Products
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSFood (Health) Supplement Retailers
NAICS2007Medicinal & Botanical Mfg
NAICS2007Other Direct Selling Establishments
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Other Direct Selling Establishments
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICMisc Food Stores



  • Poslední aktualizace: 19.06.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardJ. Stanley Fredrick8430.01.200930.01.2009
President, Chief Executive Officer, Chief Financial OfficerLanden Fredrick5101.04.2024
Regional President EMEAA, Central and South AmericaChristopher Simons60
Senior Vice President, TreasurerRonald Norman64
General Counsel and Corporate SecretaryErin Barta53